Abstract
Background: NeuroEPO, is a nasal pharmaceutical solution of recombinant human ery
Cite
CITATION STYLE
APA
Pérez, L., Sosa, S., Bringas, G., López, D., Valenzuela, C., Peñalver, A. I., … Urrutia, N. (2020). NeuroEPO in mild‐to‐moderate Alzheimer’s disease. Alzheimer’s & Dementia, 16(S9). https://doi.org/10.1002/alz.036167
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free